FDAnews Announces — FDA Quality Metrics Survival Guide: How Mid-Sized Pharma Companies Can Prepare Webinar, Sponsored by Sparta, March 30, 2017
Falls Church, VA (PRWEB) March 22, 2017 -- FDA resources are stretched thin due to the growth of the pharmaceutical industry. This has slowed drug approvals, sent drug prices soaring and brought innovation to a halt.
Although the FDA is taking action to address these issues, the solution is about to create a massive burden on mid-sized pharma companies.
Attend this webinar to learn what steps to take to prepare for the FDA Quality Metrics Program.
By the end, attendees will understand:
- Why the FDA is changing their approach to quality oversight
- How it will impact mid-sized companies
- Steps to take to survive the changes
Register today and get prepared for the coming changes.
Meet the Presenter:
Joby George, Product Manager, Sparta Systems, Inc.
Joby has been with Sparta for over 11 years with experience in the support, services, and pre-sales organizations. He has lead the effort on various Sparta solutions, such as Electronic Regulatory Report and TrackWise QualityView. His primary responsibility today is leading & defining the efforts for Stratas SaaS-based solutions.
Who Will Benefit
Quality affairs
Quality control
Regulatory affairs
IT professionals
Webinar Details:
FDA Quality Metrics Survival Guide
How Mid-Sized Pharma Companies Can Prepare
Sponsored by Sparta
**FDAnews Free Webinar**
March 30, 2017 — 1:30 p.m. – 2:30 p.m. ET
http://info.fdanews.com/fda-quality-metrics-survival-guide
Easy Ways to Register:
Online: http://info.fdanews.com/fda-quality-metrics-survival-guide
By phone: 888-838-5578 or 703-538-7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Michelle Butler, FDANEWS, http://www.fdanews.com, +1 (703) 538-7665, [email protected]
Share this article